Figure 1 | British Journal of Cancer

Figure 1

From: Combination of cetuximab with chemoradiation, trastuzumab or MAPK inhibitors: mechanisms of sensitisation of cervical cancer cells

Figure 1

Effect of RxT, cisplatin or cetuximab treatments on the proliferation and cell-cycle distribution of A431, Caski and C33A cells. (A) Effects of different doses of RxT in clonogenic assays (CA). (B) Effects of different concentrations of cisplatin in MTT assay. (C) Effects of cetuximab (100 μg ml−1) in CA. (D) Effects of cetuximab treatment in MTT assay. (E) Effects of cetuximab treatment (100 μg ml−1) on cell-cycle phase distribution analysis by flow cytometry. (F) Induction of apoptotic bodies by cetuximab treatment (100 μg ml−1) visualised by Hoechst staining. Student's t-test *P<0.05, compared to controls.

Back to article page